Tag: Triple-negative breast cancer
-
Therapeutic Vulnerability Uncovered in Aggressive Triple-Negative Breast Cancer Subtype
Breakthrough in Aggressive TNBC Subtype A landmark study published in Science Translational Medicine reveals a previously unrecognized therapeutic vulnerability in an aggressive subtype of triple-negative breast cancer (TNBC). Conducted by researchers at The University of Texas MD Anderson Cancer Center, the work provides new insight into how this hard-to-treat cancer might be targeted more effectively…
-
Therapeutic vulnerability uncovered in aggressive triple-negative breast cancer
Overview of the finding A new study published in Science Translational Medicine by researchers at The University of Texas MD Anderson Cancer Center reports a previously unrecognized therapeutic vulnerability in an aggressive subtype of triple-negative breast cancer (TNBC). Led by a team including Dr. Khan, the study identifies a molecular weakness that could be exploited…
-
Blocking TNBC Metastasis by Restoring Chromosomal Stability via EZH2 Inhibition
New findings link EZH2 to TNBC metastasis and chromosomal instability Triple negative breast cancer (TNBC) remains one of the most challenging cancer types to treat, largely due to its propensity to spread to distant organs. A new preclinical study led by Weill Cornell Medicine uncovers a surprising mechanism: an enzyme called EZH2 drives abnormal cell…